Pharmaceutical

Filter

Current filters:

None

Popular Filters

126 to 150 of 7171 results

Age-related macular degeneration treatment market to reach $10 billion by 2023

Age-related macular degeneration treatment market to reach $10 billion by 2023

04-12-2014

The market for treatments of age-related macular degeneration across seven major countries will almost…

AvastinEuropeEyleaFovistaLucentisMarkets & MarketingOphthalmicsPharmaceuticalUSA

Biogen shares rise as it pledges to progress Alzheimer’s drug

Biogen shares rise as it pledges to progress Alzheimer’s drug

03-12-2014

US biotech firm Biogen Idec has said that it will pursue a Phase III program for its Alzheimer’s disease…

BIIB037Biogen IdecNeurologicalPharmaceuticalResearchUSA

Actelion submits selexipag for EMA marketing authorization in PAH

Actelion submits selexipag for EMA marketing authorization in PAH

03-12-2014

Swiss biotech firm Actelion has submitted a centralized Marketing Authorization Application to the European…

ActelionCardio-vascularEuropePharmaceuticalRegulationselexipag

PTC launches Translarna for DMD in Germany

PTC launches Translarna for DMD in Germany

03-12-2014

US biotech company PTC Therapeutics has announced that Translarna (ataluren) is commercially available…

CNS DiseasesGermanyMarkets & MarketingPharmaceuticalPTC TherapeuticsTranslarna

Alizé Pharma acquires exclusive worldwide rights for new peptide to tackle bone diseases

03-12-2014

Alizé Pharma, a group of privately-held biopharmaceutical companies specialized in the development of…

Alize PharmaLicensingPharmaceuticalRare diseasesUSA

Urgent action needed to address Clostridium difficile infections in Europe

Urgent action needed to address Clostridium difficile infections in Europe

03-12-2014

Urgent action is needed to address the current issues relating to the management of health care-acquired…

Antibiotics and Infectious diseasesEuropeEuropean ParliamentPharmaceuticalPolitics

EMA considers next steps after annulment of Guido Rasi appointment

03-12-2014

The management board of the European Medicines Agency held an extraordinary meeting last month in Rome,…

EuropeManagementPharmaceutical

Pharma Integrates: 3rd Time to Charm

03-12-2014

Taking place at the Park Plaza Riverbank (London, UK) last month, the third Pharma Integrates conference…

HealthcarePharmaceuticalProductionResearch

World Health Organization releases new guidance on cervical cancer prevention

World Health Organization releases new guidance on cervical cancer prevention

03-12-2014

The World Health Organization has issued new guidance to prevent and control cervical cancer.

GlobalOncologyPharmaceuticalResearchSocial IssuesWorld Health Organization

Bayer boasts strong R&D pipeline and growth prospects

03-12-2014

German pharma major Bayer gave a spirited presentation of its pipeline candidates in both pharma and…

AdempasBayerEyleaFinancialHematologyOncologyOphthalmicsPharmaceuticalResearchStivargaXareltoXofigo

GeNeuro and Servier partner on multiple sclerosis drug candidate GNbAC1

03-12-2014

Switzerland-based drug developer GeNeuro has entered into a strategic partnership with French independent…

GeNeuroLicensingNeurologicalPharmaceuticalResearchServier

Evotec and Sanofi negotiate 250 million euro strategic collaboration

Evotec and Sanofi negotiate 250 million euro strategic collaboration

03-12-2014

German biotech company Evotec has entered into exclusive negotiations with French drug major Sanofi on…

EvotecFranceGermanyPharmaceuticalResearchSanofi

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

03-12-2014

Swiss pharma major Roche has acquired Ariosa Diagnostics, a privately-held company based in San Jose,…

Ariosa DiagnosticsMergers & AcquisitionsPharmaceuticalRocheUSAWomen's Health

FDA approves Sanofi’s Priftin for latent TB

FDA approves Sanofi’s Priftin for latent TB

03-12-2014

French pharma major Sanofi says that the US Food and Drug Administration has approved Priftin (rifapentine),…

Antibiotics and Infectious diseasesPharmaceuticalPriftinRegulationSanofiUSA

Russia may face a shortage of drugs against HIV

Russia may face a shortage of drugs against HIV

02-12-2014

Russia may face a shortage of drugs against HIV, due to disruptions of state auctions for the public…

Anti-viralsHealthPharmaceuticalProductionRussia

Merck Ebola vaccine is well-tolerated by volunteers in early trials

Merck Ebola vaccine is well-tolerated by volunteers in early trials

02-12-2014

The Ebola vaccine developed by pharma giant Merck & Co and NewLink has been well-tolerated by trial volunteers…

Anti-viralsMerck & CoNewLink GeneticsPharmaceuticalResearch

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

02-12-2014

The global chronic obstructive pulmonary disease and asthma devices market is expected to reach $34 billion…

Dosage formsMarkets & MarketingMedicinePharmaceuticalRespiratory and Pulmonary

Russia faces steady growth of drug prices

Russia faces steady growth of drug prices

02-12-2014

Drug prices in Russia are steadily growing, due to the deterioration of the local business environment…

PharmaceuticalPharmaceuticals policyPharmacologyPricingRussia

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

02-12-2014

The UK prime minister David Cameron is to announce a £15 million ($24 million) commitment to a new fund…

NeurologicalPharmaceuticalPoliticsResearchUK

Eli Lilly and AstraZeneca enrol first patient in Phase II/III Alzheimer's therapy trial

Eli Lilly and AstraZeneca enrol first patient in Phase II/III Alzheimer's therapy trial

02-12-2014

US drug major Eli Lilly and AstraZeneca have enrolled the first patient into AMARANTH, a Phase II/III…

AstraZenecaAZD3293Eli LillyNeurologicalPharmaceuticalResearch

FDA accepts NDA filing from AstraZeneca for Iressa

FDA accepts NDA filing from AstraZeneca for Iressa

02-12-2014

The US Food and Drug Administration has accepted for filing the New Drug Application from Iressa (gefitinib)…

AstraZenecaIressaOncologyPharmaceuticalRegulationUK

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

Exelixis’ cabozantinib fails to meet primary endpoint in Phase III prostate cancer trial

Exelixis’ cabozantinib fails to meet primary endpoint in Phase III prostate cancer trial

02-12-2014

US biotech firm Exelixis has announced top-line results from the final analysis of COMET-2, a randomized,…

cabozantinibExelixisOncologyPharmaceuticalResearchUSA

126 to 150 of 7171 results

Back to top